Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma
Completed · Phase 1
Conditions studied: Leukemia, Lymphoma
In brief
RATIONALE: Drugs used in chemotherapy work in different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: This phase I trial is studying the side effects and best dose of arsenic trioxide in treating young patients with leukemia or lymphoma.
Key facts
- Study ID
- NCT00020111
- Run by
- National Cancer Institute (NCI)
- Starts
- 2000-03-01
- Last updated by the study team
- 2015-04-29
Who can join
Age: 2 and older, up to 21. Sex: any. Healthy volunteers: not accepted.
Where it is running
- City of Hope Comprehensive Cancer Center — Duarte, California, United States
- Rebecca and John Moores UCSD Cancer Center — La Jolla, California, United States
- Children's Hospital Los Angeles — Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
- Children's Hospital of Orange County — Orange, California, United States
- Lucile Packard Children's Hospital at Stanford University Medical Center — Palo Alto, California, United States
- UCSF Comprehensive Cancer Center — San Francisco, California, United States
- County of Los Angeles Harbor-UCLA Medical Center — Torrance, California, United States
- Children's National Medical Center — Washington D.C., District of Columbia, United States
- AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish Rite Campus — Atlanta, Georgia, United States
- Children's Memorial Hospital - Chicago — Chicago, Illinois, United States
- Riley Children Cancer Center at Riley Hospital for Children — Indianapolis, Indiana, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center — Kansas City, Kansas, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland, United States
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support — Bethesda, Maryland, United States
- Floating Hospital for Children — Boston, Massachusetts, United States
- Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute — Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States
- Children's Hospital of Michigan — Detroit, Michigan, United States
- Mayo Clinic Cancer Center — Rochester, Minnesota, United States
- University of Mississippi Medical Center — Jackson, Mississippi, United States
- Children's Mercy Hospital — Kansas City, Missouri, United States
- Cardinal Glennon Children's Hospital — St Louis, Missouri, United States
- St. Louis Children's Hospital — St Louis, Missouri, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.